Summit Street Capital Management LLC lifted its stake in Humana Inc. (NYSE:HUM - Free Report) by 33.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 32,683 shares of the insurance provider's stock after acquiring an additional 8,132 shares during the quarter. Humana accounts for 2.9% of Summit Street Capital Management LLC's investment portfolio, making the stock its 14th largest position. Summit Street Capital Management LLC's holdings in Humana were worth $8,292,000 as of its most recent filing with the SEC.
Other large investors have also recently made changes to their positions in the company. FPC Investment Advisory Inc. acquired a new position in shares of Humana in the 4th quarter worth approximately $27,000. Centricity Wealth Management LLC acquired a new position in shares of Humana in the 4th quarter worth approximately $30,000. LFA Lugano Financial Advisors SA lifted its holdings in shares of Humana by 56.3% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after acquiring an additional 45 shares during the last quarter. OFI Invest Asset Management acquired a new position in shares of Humana in the 4th quarter worth approximately $33,000. Finally, Transce3nd LLC acquired a new stake in Humana during the 4th quarter worth approximately $38,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on HUM. Guggenheim began coverage on shares of Humana in a report on Wednesday, April 9th. They set a "buy" rating and a $326.00 target price on the stock. Oppenheimer increased their target price on shares of Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a report on Thursday, May 1st. Truist Financial reduced their target price on shares of Humana from $325.00 to $305.00 and set a "hold" rating on the stock in a report on Monday, May 12th. Raymond James upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price on the stock in a report on Thursday, May 1st. Finally, Barclays increased their target price on shares of Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a report on Friday, April 11th. Seventeen research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $286.81.
Get Our Latest Report on HUM
Humana Stock Performance
Shares of Humana stock traded up $7.89 on Tuesday, reaching $255.23. 1,878,205 shares of the stock were exchanged, compared to its average volume of 1,770,415. Humana Inc. has a 1-year low of $212.45 and a 1-year high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The business has a fifty day moving average price of $262.98 and a two-hundred day moving average price of $269.38. The firm has a market capitalization of $30.80 billion, a PE ratio of 25.65, a PEG ratio of 2.05 and a beta of 0.49.
Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The firm's revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $7.23 earnings per share. As a group, research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.
Humana Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.39%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is presently 25.04%.
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles

Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.